High level of persistent liver injury is one of clinical characteristics in treatment‐naïve acute onset autoimmune hepatitis: experience in a community hospital

Keiichi Fujiwara(Chiba University), Osamu Yokosuka(Chiba University), Shin Yasui, Katsushi Seza(Teikyo University Chiba Medical Center), Masaya Saito(University of Nagasaki), Masayuki Nakano(Nihon University), Yoshihiro Fukuda(Chiba University)
Journal of Hepato-Biliary-Pancreatic Sciences
January 11, 2016
10.1002/jhbp.319
Cited by 8

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
|Radiology|2011|354
cHCC‐CCA
|Hepatology|2018|333
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma.A study of 57 autopsy-proven cases
|Cancer|1977|262